Highlights Myriad Group AG

Equities

Delayed Swiss Exchange Other stock markets			5-day change	1st Jan Change
- ^CHF	-.--%		-27.92%	-62.93%

Jul. 03	Syncona Invests Additional $42.5 Million in Beacon Therapeutics	MT
Jun. 20	Syncona Invests in Two Oncology Companies	MT

Syncona Invests Additional $42.5 Million in Beacon Therapeutics	Jul. 03	MT
Syncona Invests in Two Oncology Companies	Jun. 20	MT
Syncona Posts Swings to Profit for FY24; Total Investment Income Rises	Jun. 20	MT
Syncona’s Freeline, SwanBio Combine to Form Spur Therapeutics	Jun. 17	MT
Syncona to Sell Stake in Portfolio Company to Century Therapeutics	Apr. 11	MT
Syncona’s Takeover of Freeline Therapeutics Becomes Effective	Feb. 20	MT
Syncona to Take Over Freeline Therapeutics	Nov. 22	MT
Syncona Swings to Fiscal H1 Loss; Invest Income Falls	Nov. 16	MT
Earnings Flash (SYNC.L) SYNCONA Posts Fiscal H1 Loss GBX-8.01	Nov. 16	MT
Syncona Submits Takeover Bid for Freeline Therapeutics	23-10-18	MT
Syncona Launches Up to GBP40 Million Share Buyback Program	23-09-29	MT
Myriad : Syncona Expands Investment In Quell Therapeutics By $35 Million	21-02-11	MT
Myriad : Syncona's Expects COVID-19 to Not impact Valuations as Net Asset Value Declines in Q4 2020	21-02-11	MT
Myriad : Syncona's Autolus Prices $100 Million Public Offering in US	21-02-10	MT
Myriad : Syncona's Achilles Therapeutic Mulls IPO in US	21-02-05	MT
Myriad : Earnings Flash (SYNC.L) SYNCONA Posts H1 EPS GBX17.86	20-11-19	MT
Myriad Group AG Provides Earnings Guidance for the Year Ended December 31, 2017	18-03-20	CI
Rights Issue: 1 new share @ 0.5 CHF for 3 existing shares	17-08-27	FA
Myriad Group AG Announces Earnings Results for the Half Year of 2017	17-07-27	CI
Myriad Group AG Launches New Service to Reduce SIM-Swap Fraud	17-03-13	CI

No results for this search